12:00 AM
 | 
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Chiesi, Eddingpharm sales and marketing update

Eddingpharm and Chiesi Farmaceutici will form a 51/49 JV, Chiesi Edding Hong Kong Ltd., to commercialize two of Chiesi Farmaceutici's respiratory drugs in China. Chiesi...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >